Global Allergy Relieving Eye Drops Market 2024-2028
The allergy relieving eye drops market is forecasted to grow by USD 373.2 mn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the allergy relieving eye drops market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence and incidence of eye infections, expanded geriatric populace, and increased prevalence of allergic conjunctivitis.
Technavio's allergy relieving eye drops market is segmented as below:
By Product
- Antihistamines
- Non-steroidal anti-Inflammatory drugs
- Vasoconstrictors
- Others
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the growing adoption of generics as one of the prime reasons driving the allergy relieving eye drops market growth during the next few years. Also, high cost of prescription drugs and ascend in mindfulness about eye-related disorders will lead to sizable demand in the market.
The report on the allergy relieving eye drops market covers the following areas:
- Allergy relieving eye drops market sizing
- Allergy relieving eye drops market forecast
- Allergy relieving eye drops market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading allergy relieving eye drops market vendors that include AbbVie Inc., Astellas Pharma Inc., Bausch Health Companies Inc., Dr Reddys Laboratories Ltd., Johnson and Johnson Services Inc., Lupin Ltd., Nicox S.A., Novartis AG, Ocular Therapeutix Inc, Pfizer Inc., Prestige Consumer Healthcare Inc., ROHTO Pharmaceutical Co. Ltd, Rynel Clifton Pharma Pvt. Ltd., Santen Pharmaceutical Co. Ltd., Similasan Corp. USA, Starpharma Holdings Ltd, Sumitomo Pharma Co. Ltd., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the allergy relieving eye drops market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.